注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Redhill Biopharma Ltd 是一家總部位於以色列的專業生物製藥公司,主要專注於胃腸道 (GI) 和傳染病。該公司專注於美國(美國)胃腸道相關產品 Movantik(naloxegol)、Talicia(奧美拉唑、阿莫西林和利福布丁)和 Aemcolo(利福黴素)的商業化。公司產品線的一部分包括六種候選藥物 RHB-204,專用於非結核分枝桿菌 (NTM) 治療,RHB-104專用於克羅恩病,RHB-102止吐藥昂丹司瓊,正在開髮用於多種胃腸道適應症,RHB-106口服膠囊用於腸道準備的製劑,Opaganib 一種抑製劑,口服給藥,具有抗癌、抗炎和抗病毒活性,以及針對多種適應症的絲氨酸蛋白酶 RHB-107 抑製劑,包括 COVID-19、癌症、炎症性肺病和胃腸道疾病。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Alessandro E. Della Cha | 58 | 2021 | Independent Director |
Ira N. Kalfus | 61 | 2010 | Member of Advisory Board |
Shmuel Cabilly | 72 | 2019 | Independent Director |
Werner Tschollar | - | - | Member of Advisory Board |
Ran Oren | - | - | Member of Advisory Board |
Thomas Julius Borody | - | - | Member of Advisory Board |
Yechezkel Barenholz | - | - | Member of Advisory Board |
Jerry Rosenblatt | - | - | Member of Advisory Board |
Kenneth Reed | 68 | 2009 | Independent Director |
Abe Schwartz | - | - | Member of Advisory Board |
Matthew Scott Harris | 70 | 2017 | Member of Advisory Board |
Alla Felder | 50 | 2019 | Independent Director |
Ofer Tsimchi | 65 | 2011 | Independent Director |
Eric Swenden | 80 | 2010 | Independent Director |
Dror Ben-Asher | 58 | 2009 | Co-Founder, Chairman & CEO |
Rick D. Scruggs | 64 | 2016 | Chief Commercial Officer, President of RedHill Biopharma Inc. & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核